IAP0971
Sponsors
SUNHO（China）BioPharmaceutical CO., Ltd.
Conditions
Advanced Malignant NeoplasmAdvanced Malignant TumorsAdvanced or Metastatic Non-small Cell Lung CancerBladder Cancer
Phase 1
A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors
NCT05396391
Start: 2022-06-22End: 2024-11-30Target: 140Updated: 2023-07-20
A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors
RecruitingNCT06223841
Start: 2024-03-01End: 2027-03-01Target: 50Updated: 2024-02-20
A Study of IAP0971 in Combination With Bacillus Calmette Guerin in High Risk Non-muscular Invasive Bladder Cancer
Not yet recruitingNCT06255964
Start: 2024-02-15End: 2026-12-07Target: 236Updated: 2024-02-13
A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors
RecruitingNCT06581419
Start: 2024-12-31End: 2029-08-01Target: 78Updated: 2025-01-15